TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34426507

Group type: EXPERIMENTAL
Intervention: Plasma adiponectin levels of 19.2 μg/mL (3rd quartile)
Number of subjects: 756219

Group type: EXPERIMENTAL
Intervention: Plasma adiponectin levels of 13.9 μg/mL (2nd quartile)
Number of subjects: 756219

Group type: EXPERIMENTAL
Intervention: Plasma adiponectin levels of 9.2 μg/mL (1st quartile)
Number of subjects: 756219

Group type: EXPERIMENTAL
Intervention: 1 μg/mL lower plasma adiponectin
Number of subjects: 756219

Group type: EXPERIMENTAL
Intervention: One-sample MR (5 genetic variants)
Number of subjects: 756219

Group type: EXPERIMENTAL
Intervention: Two-sample MR (10 genetic variants)
Number of subjects: 756219
Study: 33129304

Group type: EXPERIMENTAL
Intervention: Octreotide
Number of subjects: 106

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106
Study: 34611811

Group type: EXPERIMENTAL
Intervention: Deferred consent in the ULTRA trial
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Preferred consent procedure for the ULTRA trial
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Trust in physicians and scientific research
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Physicians' agreement with deferred consent in the ULTRA trial
Number of subjects: 135
Study: 35324322

Group type: EXPERIMENTAL
Intervention: Digital literacy assessment tool
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Traditional consent process for tech-savvy individuals
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Tailored consent process for individuals with weaker skills
Number of subjects: 161
Study: 35858825

Group type: EXPERIMENTAL
Intervention: Self-actuated molecular-electrochemical system for detecting SARS-CoV-2 RNAs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Double-blind testing and 10-in-1 pooled testing
Number of subjects: 0
Study: 33606921

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32932482

Group type: EXPERIMENTAL
Intervention: Randomization of pixel positions in hologram display using a liquid crystal modulator
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Photo-magnetic transparent cobalt-doped yttrium iron garnet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Micromirror-driven raster scanning of femtosecond pulses
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Recorded holographic patterns
Number of subjects: 0
Study: 33998882

Group type: EXPERIMENTAL
Intervention: Cannabidiol (CBD) chewing gum (50 mg)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo chewing gum
Number of subjects: 32
Study: 32623524

Group type: EXPERIMENTAL
Intervention: Ozonated water mouthwash
Number of subjects: 42

Group type: COMPARATOR
Intervention: Bidistilled water mouthwash (Control)
Number of subjects: 42
Study: 35644221

Group type: EXPERIMENTAL
Intervention: Prasugrel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ticagrelor
Number of subjects: 0
Study: 34107989

Group type: EXPERIMENTAL
Intervention: Panoramic radiography (PAN) analysis prediction equations (PAN-D)
Number of subjects: 292

Group type: COMPARATOR
Intervention: Cone-beam computed tomography (CBCT)
Number of subjects: 292
Study: 35420695

Group type: EXPERIMENTAL
Intervention: Stereotactic adjuvant pelvic radiation to a dose of 30 Gy in 5 fractions administered every other day or once weekly
Number of subjects: 61
Study: 33579257

Group type: EXPERIMENTAL
Intervention: Leaflet provided with hypothetical screening results (intervention group)
Number of subjects: 972

Group type: COMPARATOR
Intervention: No leaflet provided (control group)
Number of subjects: 972
Study: 35797111

Group type: EXPERIMENTAL
Intervention: PiCCO-guided fluid resuscitation
Number of subjects: 78
Study: 33649979

Group type: EXPERIMENTAL
Intervention: Prophylactic enoxaparin (4000 IU)
Number of subjects: 436

Group type: COMPARATOR
Intervention: Higher dosing regimen (> 4000 IU)
Number of subjects: 436
Study: 34027769

Group type: EXPERIMENTAL
Intervention: Mindfulness group
Number of subjects: 74

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 74
Study: 33170321

Group type: EXPERIMENTAL
Intervention: Circulating Tumor-Associated Cells (C-TACs)
Number of subjects: 5090
Study: 35705346

Group type: EXPERIMENTAL
Intervention: Peer-driven intervention with study buddy recruitment and standard retention outreach
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard retention outreach by study staff
Number of subjects: 0
Study: 35196114

Group type: EXPERIMENTAL
Intervention: InnoSpire Go mesh nebulizer
Number of subjects: 17

Group type: COMPARATOR
Intervention: Compressor driven jet nebulizer
Number of subjects: 17
Study: 34912512

Group type: EXPERIMENTAL
Intervention: Vitamin B6 (80 mg)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study: 33089287

Group type: EXPERIMENTAL
Intervention: Digital clear aligners (experimental group)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Fixed appliances (control group)
Number of subjects: 33
Study: 35334856

Group type: EXPERIMENTAL
Intervention: Ketogenic Formula (KF)
Number of subjects: 20
Study: 32180212

Group type: EXPERIMENTAL
Intervention: Sexual intercourse at least three times a week
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.4 mg/d
Number of subjects: 225

Group type: COMPARATOR
Intervention: Standard therapy alone
Number of subjects: 225
Study: 36463724

Group type: EXPERIMENTAL
Intervention: GRASP (GRoup trAining for Social skills in Psychosis) plus treatment-as-usual (TAU)
Number of subjects: 48

Group type: COMPARATOR
Intervention: TAU alone
Number of subjects: 48
Study: 33875426

Group type: EXPERIMENTAL
Intervention: Clofazimine 300 mg daily for 3 days, followed by 100 mg daily for 11 days
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Clofazimine (loading doses of 200 and 300 mg)
Number of subjects: 15
Study: 33118436

Group type: EXPERIMENTAL
Intervention: Ambivalent sexism and victim's gender role
Number of subjects: 139

Group type: COMPARATOR
Intervention: Traditional gender role video
Number of subjects: 139

Group type: COMPARATOR
Intervention: Nontraditional gender role video
Number of subjects: 139
Study: 33481787

Group type: EXPERIMENTAL
Intervention: Vaccine group
Number of subjects: 739

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 739

Group type: EXPERIMENTAL
Intervention: BEN presence
Number of subjects: 739

Group type: EXPERIMENTAL
Intervention: Female gender
Number of subjects: 739

Group type: EXPERIMENTAL
Intervention: Cannabis use
Number of subjects: 739
Study: 35671089

Group type: EXPERIMENTAL
Intervention: Mobile phone ownership
Number of subjects: 3299

Group type: EXPERIMENTAL
Intervention: Reported daily use of mobile phones
Number of subjects: 3299

Group type: EXPERIMENTAL
Intervention: Comfort receiving screening results via SMS
Number of subjects: 3299

Group type: EXPERIMENTAL
Intervention: Higher education level
Number of subjects: 3299

Group type: EXPERIMENTAL
Intervention: Missing work to attend screening
Number of subjects: 3299

Group type: EXPERIMENTAL
Intervention: Previous cervical cancer screening
Number of subjects: 3299

Group type: EXPERIMENTAL
Intervention: Overall treatment uptake
Number of subjects: 3299

Group type: EXPERIMENTAL
Intervention: Sharing a mobile phone with partner/spouse
Number of subjects: 3299

Group type: COMPARATOR
Intervention: Type of notification method (SMS, phone call, home visit)
Number of subjects: 3299
Study: 32772097

Group type: EXPERIMENTAL
Intervention: CBT+BA+CM
Number of subjects: 120

Group type: COMPARATOR
Intervention: CBT+BA
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: CM
Number of subjects: 120
Study: 36002111

Group type: EXPERIMENTAL
Intervention: Qualitative insights from patients regarding dietary changes post-diagnosis
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Medical Influences
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Health Beliefs
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Static Diets
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Navigating External Influences
Number of subjects: 29
Study: 33504277

Group type: EXPERIMENTAL
Intervention: Re-randomization tests
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Minimization and permuted blocks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Asymptotic tests
Number of subjects: 0
Study: 32402931

Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 506

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 506
Study: 32729286

Group type: EXPERIMENTAL
Intervention: Performance-Based Financing (PBF)
Number of subjects: 11010

Group type: EXPERIMENTAL
Intervention: Performance-Based Financing (PBF) combined with equity measures
Number of subjects: 11010

Group type: COMPARATOR
Intervention: Standard PBF
Number of subjects: 11010
Study: 33978698

Group type: EXPERIMENTAL
Intervention: Intrathoracic anastomosis
Number of subjects: 245

Group type: COMPARATOR
Intervention: Cervical anastomosis
Number of subjects: 245
Study: 32778102

Group type: EXPERIMENTAL
Intervention: Disease-specific PROM
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Generic PROM
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both disease-specific and generic PROMs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (no PROMs)
Number of subjects: 0
Study: 35605599

Group type: EXPERIMENTAL
Intervention: VNeST plus anodal tDCS stimulation of left inferior frontal gyrus (IFG)
Number of subjects: 3

Group type: COMPARATOR
Intervention: VNeST plus sham stimulation
Number of subjects: 3
Study: 32998184

Group type: EXPERIMENTAL
Intervention: Internal migration of children
Number of subjects: 791

Group type: COMPARATOR
Intervention: No migration of children
Number of subjects: 791
Study: 36285573

Group type: COMPARATOR
Intervention: Standard bolus
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Split bolus 70/30 with 20% increment
Number of subjects: 25
Study: 34383903

Group type: EXPERIMENTAL
Intervention: Pecan consumption (68 g) as part of a free-living diet (ADD group, n = 16)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Pecan substitution (68 g) for isocaloric foods (SUB group, n = 18)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (n = 18)
Number of subjects: 56
Study: 32070409

Group type: EXPERIMENTAL
Intervention: Total ankle replacement
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ankle arthrodesis
Number of subjects: 0
Study: 34980232

Group type: EXPERIMENTAL
Intervention: ANC counseling plus BEP supplement
Number of subjects: 1836

Group type: EXPERIMENTAL
Intervention: ANC counseling plus BEP supplement plus 2 doses azithromycin
Number of subjects: 1836

Group type: EXPERIMENTAL
Intervention: ANC counseling plus BEP supplement plus daily single dose of nicotinamide and choline
Number of subjects: 1836

Group type: COMPARATOR
Intervention: ANC counseling only (control group)
Number of subjects: 1836
Study: 35799221

Group type: EXPERIMENTAL
Intervention: Massage at cervical dilatation of 7 cm for 20 minutes
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Massage at cervical dilatation of 5 cm for 20 minutes
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Massage at cervical dilatation of 9 cm for 20 minutes
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Massage group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (routine care without massage)
Number of subjects: 60
Study: 32116199

Group type: EXPERIMENTAL
Intervention: Dexamethasone 8mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Ondansetron 4mg
Number of subjects: 60
Study: 33175440

Group type: EXPERIMENTAL
Intervention: Infant and early childhood mental health consultation (IECMHC)
Number of subjects: 1195

Group type: COMPARATOR
Intervention: Technical assistance (TA)
Number of subjects: 1195

Group type: COMPARATOR
Intervention: BehaviorHelp (BH) system overall
Number of subjects: 1195
Study: 32032196

Group type: EXPERIMENTAL
Intervention: Prosthetic mesh
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 70
Study: 34669637

Group type: EXPERIMENTAL
Intervention: 22-point risk score based on multivariable model for predicting postoperative pneumonia (POP)
Number of subjects: 3853
Study: 35321739

Group type: EXPERIMENTAL
Intervention: Prediction-aided decisions during bDMARD tapering
Number of subjects: 279
Study: 32618436

Group type: EXPERIMENTAL
Intervention: Chemotherapy with high-risk regimens including cisplatin or carboplatin and doxorubicin (19 patients), or cisplatin or carboplatin alone (3 patients)
Number of subjects: 22
Study: 35926202

Group type: EXPERIMENTAL
Intervention: Cervical dilators with misoprostol
Number of subjects: 347

Group type: COMPARATOR
Intervention: Misoprostol alone
Number of subjects: 347
Study: 33531152

Group type: COMPARATOR
Intervention: Multilayer cage rearing (MC)
Number of subjects: 2400

Group type: EXPERIMENTAL
Intervention: Narasin inclusion in diets
Number of subjects: 2400

Group type: COMPARATOR
Intervention: Multilayer cage (MC) and plastic net (PN) rearing systems
Number of subjects: 2400

Group type: COMPARATOR
Intervention: Multilayer cage (MC) compared with flooring litter (FL)
Number of subjects: 2400

Group type: EXPERIMENTAL
Intervention: Flooring litter (FL)
Number of subjects: 2400

Group type: EXPERIMENTAL
Intervention: Narasin combined with multilayer cage (MC)
Number of subjects: 2400

Group type: EXPERIMENTAL
Intervention: Plastic net (PN)
Number of subjects: 2400

Group type: COMPARATOR
Intervention: Multilayer cage (MC)
Number of subjects: 2400
Study: 36355640

Group type: EXPERIMENTAL
Intervention: Just-in-time adaptive intervention (JITAI) with personalized pushes (text-based notifications)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (no JITAI)
Number of subjects: 70
Study: 34544324

Group type: EXPERIMENTAL
Intervention: Pregabalin and exercise therapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Exercise therapy alone
Number of subjects: 40
Study: 35654972

Group type: EXPERIMENTAL
Intervention: Liraglutide (a GLP‐1 receptor agonist)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 300
Study: 33872345

Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 26

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 26
Study: 32727733

Group type: EXPERIMENTAL
Intervention: 30% fluence rate of photodynamic therapy (PDT)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: 40% fluence rate of photodynamic therapy (PDT)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: 50% fluence rate of photodynamic therapy (PDT)
Number of subjects: 51
Study: 32450215

Group type: EXPERIMENTAL
Intervention: 3D video-system
Number of subjects: 70

Group type: COMPARATOR
Intervention: 2D video-system
Number of subjects: 70
Study: 35352703

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy intervention teaching pain self-management skills in 12 weekly, 90-minute groups
Number of subjects: 814

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 814

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy intervention
Number of subjects: 814
Study: 33972581

Group type: EXPERIMENTAL
Intervention: Citric-acid dialysate (C1.5) with dCa of 1.50 mmol/l
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Acetic-acid dialysate with dCa of 1.25 mmol/l (A1.25)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Acetic-acid dialysate with dCa of 1.50 mmol/l (A1.5)
Number of subjects: 13
Study: 32604162

Group type: EXPERIMENTAL
Intervention: FOLFIRINOX (FFX)
Number of subjects: 413

Group type: COMPARATOR
Intervention: gemcitabine plus nab-paclitaxel (GNP)
Number of subjects: 413

Group type: EXPERIMENTAL
Intervention: FFX-GNP
Number of subjects: 413

Group type: COMPARATOR
Intervention: GNP-FFX
Number of subjects: 413
Study: 35411183

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Medication
Number of subjects: 88
Study: 33417730

Group type: EXPERIMENTAL
Intervention: Daridorexant 50 mg once daily for 5 consecutive days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Daridorexant 50 mg
Number of subjects: 0
Study: 36293971

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (0.3 g/kg body weight)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 34388379

Group type: EXPERIMENTAL
Intervention: Bevacizumab (VEGF inhibitor) added to Erlotinib (EGFR inhibitor)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Erlotinib (EGFR inhibitor) alone
Number of subjects: 0
Study: 35167361

Group type: COMPARATOR
Intervention: Online Yoga (OY) only
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Online Yoga with Facebook (OYFB)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Both groups (OY and OYFB)
Number of subjects: 60
Study: 34208829

Group type: EXPERIMENTAL
Intervention: SCD acute plasma samples
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: SCD steady-state plasma samples
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Chemical agents acting on RBC membrane channels
Number of subjects: 54

Group type: COMPARATOR
Intervention: Recombinant Annexin V pre-treatment
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Modulators of RBC membrane channels (activating Piezo1 Ca2+ channel)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Blocking Ca2+-dependent K+ Gardos channel
Number of subjects: 54
Study: 32369761

Group type: EXPERIMENTAL
Intervention: 8-week proprioceptive training, 5 times per week for 10 minutes
Number of subjects: 16

Group type: COMPARATOR
Intervention: Nontraining group
Number of subjects: 16
Study: 35051662

Group type: EXPERIMENTAL
Intervention: Connect through PLAY intervention
Number of subjects: 30

Group type: COMPARATOR
Intervention: Active health curriculum control
Number of subjects: 30
Study: 34810363

Group type: EXPERIMENTAL
Intervention: Muscle energy technique
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Occlusal splint therapy
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Combined treatment with education for self‐management and counseling
Number of subjects: 160

Group type: COMPARATOR
Intervention: Education for self‐management and counseling (Control)
Number of subjects: 160
Study: 35483981

Group type: EXPERIMENTAL
Intervention: Postoperative stroke
Number of subjects: 383

Group type: EXPERIMENTAL
Intervention: Delirium
Number of subjects: 383
Study: 32879932

Group type: EXPERIMENTAL
Intervention: 1 mm abutment with thin mucosa
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 1 mm abutment with thick mucosa
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 3 mm abutment with thin mucosa
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 3 mm abutment with thick mucosa
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 1 mm abutment
Number of subjects: 80

Group type: COMPARATOR
Intervention: 3 mm abutment
Number of subjects: 80
Study: 34748133

Group type: EXPERIMENTAL
Intervention: Informational video about autism
Number of subjects: 152

Group type: COMPARATOR
Intervention: Active control group
Number of subjects: 152
Study: 33966335

Group type: EXPERIMENTAL
Intervention: TTNS once a week for 30 minutes for 12 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: TTNS three times a week for 30 minutes for 12 weeks
Number of subjects: 60
Study: 33109641

Group type: EXPERIMENTAL
Intervention: IA injection of HA+CS combined with duloxetine
Number of subjects: 150

Group type: COMPARATOR
Intervention: IA injection of HA+CS alone
Number of subjects: 150
Study: 35030257

Group type: EXPERIMENTAL
Intervention: Catheter ablation
Number of subjects: 259

Group type: COMPARATOR
Intervention: Escalated antiarrhythmic drug therapy
Number of subjects: 259

Group type: COMPARATOR
Intervention: Escalated antiarrhythmic drug therapy (specifically amiodarone)
Number of subjects: 259
Study: 34160595

Group type: COMPARATOR
Intervention: Placebo plus psychosocial treatment
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Antipsychotic medication plus psychosocial treatment
Number of subjects: 59

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 59
Study: 35058236

Group type: EXPERIMENTAL
Intervention: 200 mg CC-90001
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: 400 mg CC-90001
Number of subjects: 210

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: 400 mg CC-90001 (PF-ILD substudy)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Placebo (PF-ILD substudy)
Number of subjects: 210
Study: 34854347

Group type: EXPERIMENTAL
Intervention: Technology-based plus positive psychological training (PPT)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Technology-based intervention alone (comparison group)
Number of subjects: 18
Study: 35822730

Group type: EXPERIMENTAL
Intervention: Low-pressure pneumoperitoneum (8 mm Hg) with deep neuromuscular blockade (posttetanic count 1-2)
Number of subjects: 178

Group type: COMPARATOR
Intervention: Standard-pressure pneumoperitoneum (12 mm Hg) with moderate neuromuscular blockade (train-of-four 1-2)
Number of subjects: 178
Study: 36357967

Group type: EXPERIMENTAL
Intervention: Intervention group (approach to reduce sedentary behaviour)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control group (usual care during hospitalisation)
Number of subjects: 86
Study: 33565826

Group type: EXPERIMENTAL
Intervention: Patient blood management strategies implemented (207 patients)
Number of subjects: 409

Group type: COMPARATOR
Intervention: No patient blood management strategies (202 patients)
Number of subjects: 409
Study: 33045374

Group type: EXPERIMENTAL
Intervention: 10% daily contrast increment protocol
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: 5% daily contrast increment protocol
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: 0% daily contrast increment protocol
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: 10% for first 4 weeks then reset to 20% and repeat 10% increment for the final 4 weeks
Number of subjects: 63

Group type: COMPARATOR
Intervention: All protocols (10%, 5%, 0%, and 10% reset)
Number of subjects: 63
Study: 35988922

Group type: EXPERIMENTAL
Intervention: External-country causal attribution
Number of subjects: 593

Group type: COMPARATOR
Intervention: Internal-country causal attribution
Number of subjects: 593
Study: 33744191

Group type: EXPERIMENTAL
Intervention: Group-based exercise rehabilitation (GE)
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Individual exercise rehabilitation (IE)
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Home exercise rehabilitation (HE)
Number of subjects: 208

Group type: COMPARATOR
Intervention: EQ-5D-5L index
Number of subjects: 208

Group type: COMPARATOR
Intervention: Healthcare and productivity costs
Number of subjects: 208